Charles Spicer Buys 15,435 Shares of Creo Medical Limited (LON:CREO) Stock

Creo Medical Limited (LON:CREOGet Rating) insider Charles Spicer purchased 15,435 shares of Creo Medical stock in a transaction that occurred on Thursday, May 26th. The stock was purchased at an average cost of GBX 97 ($1.22) per share, for a total transaction of £14,971.95 ($18,839.75).

CREO stock opened at GBX 97.60 ($1.23) on Friday. The business’s 50-day moving average is GBX 105.50 and its two-hundred day moving average is GBX 127.69. The company has a debt-to-equity ratio of 20.53, a quick ratio of 2.17 and a current ratio of 2.52. Creo Medical Limited has a fifty-two week low of GBX 94 ($1.18) and a fifty-two week high of GBX 220 ($2.77). The company has a market cap of £176.66 million and a price-to-earnings ratio of -7.17.

Creo Medical Company Profile (Get Rating)

Creo Medical Limited engages in the research and development of electrosurgical medical devices relating to the field of surgical endoscopy in the United Kingdom. It is developing Croma, an energy platform that powers a suite of multi-modal devices to optimize treatments for patients and physicians. The company also offers Speedboat Inject, an energy multimodality instrument for flexible endoscopy; Speedboat Slim, a flexible bipolar RF and microwave device for cutting and coagulation; MicroBlate Fine, a microwave needle ablation device; MicroBlate Flex, a flexible microwave ablation device; SlypSeal Flex, a flexible haemostasis device for the treatment of upper and lower GI bleeds; and SpydrBlade Flex, a flexible bipolar RF and microwave scissor device that grasps, cuts and, coagulates highlyperfused tissues.

Further Reading

Receive News & Ratings for Creo Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Creo Medical and related companies with MarketBeat.com's FREE daily email newsletter.